BRIEF-Nivalis Therapeutics stockholders approve reverse stock split

* Nivalis Therapeutics - stockholders approved on July 19 reverse stock split of co's common stock, at ratio of 1 new share for every 4 shares outstanding
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.